These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8364347)

  • 1. Differential effects of the enantiomers R(-) and S(+) oxaprotiline on major endogenous depression, the sleep EEG and neuroendocrine secretion: studies on depressed patients and normal controls.
    Steiger A; Gerken A; Benkert O; Holsboer F
    Eur Neuropsychopharmacol; 1993 Jun; 3(2):117-26. PubMed ID: 8364347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxaprotiline in the treatment of endogenous depressed inpatients an early clinical trial.
    Schmauss M; Laakmann G; Dieterle D; Blaschke D
    Pharmacopsychiatry; 1985 Jul; 18(4):282-5. PubMed ID: 3895255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long term treatment with oxaprotiline in patients with major depression.
    Katz RJ
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(6):875-83. PubMed ID: 2813805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin reuptake inhibition vs. norepinephrine reuptake inhibition: a double-blind differential-therapeutic study with fluvoxamine and oxaprotiline in endogenous and neurotic depressives.
    Emrich HM; Berger M; Riemann D; von Zerssen D
    Pharmacopsychiatry; 1987 Mar; 20(2):60-3. PubMed ID: 3108909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immediate effects of intravenous clomipramine on sleep and sleep-related secretion in depressed patients.
    Kupfer DJ; Pollock BG; Perel JM; Jarrett DB; McEachran AB; Miewald JM
    Psychiatry Res; 1991 Mar; 36(3):279-89. PubMed ID: 2062969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sleep EEG and nocturnal secretion of cortisol and growth hormone in male patients with endogenous depression before treatment and after recovery.
    Steiger A; von Bardeleben U; Herth T; Holsboer F
    J Affect Disord; 1989; 16(2-3):189-95. PubMed ID: 2522118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Action of trimipramine on sleep and pituitary hormone secretion.
    Wiegand M; Berger M
    Drugs; 1989; 38 Suppl 1():35-42; discussion 49-50. PubMed ID: 2612388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressant plasma levels and clinical response in depressed patients treated with oxaprotiline and doxepin.
    Hrdina PD; Lapierre YD; Horn E; Bakish D; Browne M
    Int Clin Psychopharmacol; 1988 Jul; 3(3):205-14. PubMed ID: 3153709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of trimipramine on sleep EEG, penile tumescence and nocturnal hormonal secretion. A long-term study in 3 normal controls.
    Steiger A; Benkert O; Wöhrmann S; Steinseifer D; Holsboer F
    Neuropsychobiology; 1989; 21(2):71-5. PubMed ID: 2515468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone-releasing hormone (GHRH)-induced effects on sleep EEG and nocturnal secretion of growth hormone, cortisol and ACTH in patients with major depression.
    Steiger A; Guldner J; Colla-Müller M; Friess E; Sonntag A; Schier T
    J Psychiatr Res; 1994; 28(3):225-38. PubMed ID: 7932284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of long-term treatment with the MAO-A inhibitor moclobemide on sleep EEG and nocturnal hormonal secretion in normal men.
    Steiger A; Benkert O; Holsboer F
    Neuropsychobiology; 1994; 30(2-3):101-5. PubMed ID: 7800155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trimipramine and imipramine exert different effects on the sleep EEG and on nocturnal hormone secretion during treatment of major depression.
    Sonntag A; Rothe B; Guldner J; Yassouridis A; Holsboer F; Steiger A
    Depression; 1996; 4(1):1-13. PubMed ID: 9160649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind study of oxaprotiline versus clomipramine in the treatment of depressive inpatients.
    Wolfersdorf M; Binz U; Wendt G; Metzger R; Hole G
    Neuropsychobiology; 1987; 17(1-2):41-8. PubMed ID: 3306439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CGP 12.103 A versus clomipramine in the treatment of depressed inpatients--results of a double-blind study.
    Wolfersdorf M; Wendt G; Binz U; Steiner B; Hole G
    Pharmacopsychiatry; 1988 Jul; 21(4):203-7. PubMed ID: 3060885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depression and sleep disorders. The optical isomers of oxaprotiline and their effect on sleep parameters in healthy subjects.
    Gnirss FA
    Psychopathology; 1986; 19 Suppl 2():231-8. PubMed ID: 3575626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholinergic and noradrenergic neurotransmission: impact on REM sleep regulation in healthy subjects and depressed patients.
    Riemann D; Hohagen F; Fritsch-Montero R; Krieger S; Gann H; Dressing H; Muller W; Berger M
    Acta Psychiatr Belg; 1992; 92(3):151-71. PubMed ID: 1345430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A clinical test of noradrenergic involvement in the therapeutic mode of action of an experimental antidepressant.
    Katz RJ; Lott M; Landau P; Waldmeier P
    Biol Psychiatry; 1993 Feb; 33(4):261-6. PubMed ID: 8471679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sleep EEG and amitryptiline treatment in depressed inpatients.
    Mendlewicz J; Kempenaers C; de Maertelaer V
    Biol Psychiatry; 1991 Oct; 30(7):691-702. PubMed ID: 1958766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of fluoxetine upon pharmacoendocrine and sleep-EEG parameters in normal controls.
    von Bardeleben U; Steiger A; Gerken A; Holsboer F
    Int Clin Psychopharmacol; 1989 Jan; 4 Suppl 1():1-5. PubMed ID: 2536765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time course of improvement under antidepressant treatment: a survival-analytical approach.
    Stassen HH; Delini-Stula A; Angst J
    Eur Neuropsychopharmacol; 1993 Jun; 3(2):127-35. PubMed ID: 8364348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.